Cargando…
Is it possible to use Proton Pump Inhibitors in COVID-19 treatment and prophylaxis?
Coronaviruses (CoV), discovered after 1960, caused human life-threatening outbreaks. SARS-CoV2, which appeared in Wuhan, China in December 2019, causing Severe Acute Respiratory Syndrome and has different features than other coronaviruses, has been determined and the disease caused by the virus has...
Autores principales: | Taştemur, Şeyma, Ataseven, Hilmi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834647/ https://www.ncbi.nlm.nih.gov/pubmed/32679422 http://dx.doi.org/10.1016/j.mehy.2020.110018 |
Ejemplares similares
-
Proton pump inhibitors in the COVID-19 pandemic()
por: Sebastián Domingo, Juan J.
Publicado: (2021) -
Possible Effects of Proton Pump Inhibitors on Hearing Loss Development
por: Wiciński, Michał, et al.
Publicado: (2019) -
Proton Pump Inhibitor Prophylaxis After Gastric Bypass Does Not Cause Hypomagnesemia
por: Boerlage, Thomas C. C., et al.
Publicado: (2016) -
Proton pump inhibitors increase risk of COVID-19
Publicado: (2020) -
Re-thinking the possible interaction between proton pump inhibitors and capecitabine
por: Jeong, Soo Hee, et al.
Publicado: (2022)